TPR and cancer: As shown in Figure (2A and 2B) and Additional file 1, the designed hybrid Antp-TPR peptide, with its cell-permeable sequence derived from the Antennapedia homeodomain, demonstrated selective antitumor activity, discriminating between normal and cancer cells.